Home » Company » IMS Health

IMS Health

IMS Health Second Quarter 2014 Revenues Up 6.1%

Revenue for the second quarter increased 6.1 percent to $662 million, or 5.4 percent on a constant currency basis, compared with the second quarter of 2013. The company’s strong revenue performance in the second quarter was driven by a 12.7 percent increase in technology services. Information offerings revenue grew 1.8 percent. Revenue grew across all regions. Emerging markets increased 8.7 ... Read More »

IMS Health to Acquire Cegedim’s Information Solutions and CRM Businesses

IMS Health (NYSE:IMS) announced its intention to acquire certain Cegedim information solutions and Customer Relationship Management (CRM) businesses for €385 million (approximately$520 million) in cash. Cegedim is a global technology and services company specializing in healthcare.  The proposed transaction includes Cegedim’s CRM solutions that help life sciences clients in 80 countries drive sales effectiveness, optimize marketing programs across multiple channels and mitigate regulatory compliance ... Read More »

IMS Health Acquires Forcea

Advances Business Intelligence and Performance Management Capabilities, Extends IMS One Platform in Europe IMS Health has acquired Forcea, a leading Belgium-based provider of business intelligence applications and analytics, to advance performance management capabilities for hospitals and life sciences organizations around the globe.  The acquisition brings together IMS Health’s comprehensive information and technology services with Forcea’s hospital-based technology solutions to drive more effective ... Read More »

IMS Health Gains After $1.3 Billion Share Sale

IMS Health and investors including TPG Capital raised $1.3 billion after selling the stock for $20.  IMS Health Holdings Inc. shares gained 15 percent to $23. The IPO marks a return for IMS to the public markets after it was acquired by a group of private-equity funds four years ago. While private, IMS spent $900 million on acquisitions between 2011 ... Read More »

IMS Health Files Registration Statement for Initial Public Offering

IMS Health announced that it has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock. The number of shares to be offered by IMS Health and its shareholders, and the price range for the offering, have not yet been determined.  The company filed under the ... Read More »

IMS Health Acquires Pygargus

IMS Health has acquired Pygargus, an industry-leading life sciences advisory and analytics firm based in Sweden, to further advance its technology-enabled Real-World Evidence solutions and global RWE footprint. The acquisition brings together IMS Health’s market-leading RWE capabilities with Pygargus’s proprietary technology for extracting and integrating patient-anonymous information from sources that include electronic medical records, health registries and claims databases. The ... Read More »

IMS Health Acquires Diversinet’s Assets for $3.5M

Toronto-based mobile health company Diversinet agreed to sell its assets to IMS Health for about $3.5 million (US).  The sale includes Diversinet’s intellectual property, software, and customer contracts. Some employees will also be offered positions at IMS, once the deal is finalized. The asset acquisition is still subject to the approval of the company’s shareholders but a vote is scheduled ... Read More »

IMS Health Announces Acquisition of Incential Software

Expands Leading-Edge SaaS Incentive Compensation Capabilities for Life Sciences IMS Health has acquired Incential Software, an industry-leading Software-as-a-Service (SaaS) company based in Raleigh, NC, to advance its sales performance management capabilities for life sciences organizations worldwide. Incential delivers unique, cloud-based technology and services that integrate incentive compensation, data management and business intelligence applications for more effective, results-driven sales operations. The ... Read More »

IMS Health Announces Acquisition of 360 Vantage

Extends Multi-Channel Customer Relationship Management Software Capabilities for Life Sciences and Healthcare IMS Health announced the acquisition of 360 Vantage, a leading provider of cloud-based multi-channel CRM and closed loop marketing technologies, to further extend its commercial Software-as-a-Service capabilities for life sciences and healthcare organizations around the globe. The combination of IMS Health’s global footprint and 360 Vantage’s CRM applications ... Read More »

IMS Health Buys Social Media Analyst Semantelli

IMS Health has acquired social media analytics firm Semantelli for an undisclosed sum. Bridgewater, NJ-based Semantelli offers a set of cloud-based tools that automate the collection of insights into consumer and physician behavior and sentiments. Its proprietary technologies enable organizations to access, navigate and analyze both structured and unstructured data from thousands of online resources, including social networks and other ... Read More »

IMS Health Announces Acquisition of Appature

Leading-Edge, Cloud-Based Marketing Platform for Life Sciences IMS Health has acquired Appature, a leading Software-as-a-Service (SaaS) company based in Seattle, to further expand its commercial services capabilities for life sciences and healthcare organizations. Read More »

IMS Health Acquires TTC to Bolster Pharma Analytics Offering

US— IMS Health has acquired TTC, a Philadelphia-based benchmarking and analytics company which helps global life science organisations plan for and negotiate the costs of clinical trials. Under the deal IMS will integrate its evidence-based, anonymised patient and treatment outcome insights with TTC’s cost data.  This is drawn from a collection of organisations that the firms claim between them conduct ... Read More »

IMS Health Buys Analytics Firm PharmARC

IMS Health has acquired Bangalore-based PharmARC, which specializes in analytics and other services for the life sciences industry. Terms of the deal were not disclosed. Along with its HQ in India, PharmARC also has offices in Basel and New Jersey from which it offers analytic solutions to help life sciences clients make decisions relating to their sales and marketing strategies. ... Read More »

IMS Sells Off SDI Audit Businesses to InVentiv

US— Healthcare consulting firm InVentiv has agreed to buy some of the research products of SDI – which regulators said had to be sold for competition reasons following the acquisition of SDI by IMS Health.   The Federal Trade Commission (FTC) told IMS last year that it had to sell certain of SDI’s data products by the end of January, to ... Read More »